Abstract
Several findings suggest that patient outcome would be improved with individualized doses. The aim of this paper is to describe major approaches, methods and underlying basic foundations implemented, in clinical practice, for dosage individualization. Also we propose a new method codified by kinetic nomograms as reliable alternative to traditional Bayesian methods. Clinical and simulation data were reported to evaluate performances of the proposed methods. Real examples of therapeutic drug monitoring were selected. Bayesian methods were used to individualize high-dose methotrexate rate infusion and amikacin dosage regimen, and kinetic nomograms to adjust sirolimus doses. 1) Using only few measurements, Bayesian method resulted in accurate estimates of individual pharmacokinetic parameters of highdose methotrexate infusion. Targeting a pre-defined end-of-infusion level, infusion rate was individualized according to the previously obtained pharmacokinetic parameters. 2) With the same reasoning, individual pharmacokinetic parameters of amikacin were obtained by Bayesian estimation using three individual samples. Subsequent dosage adjustment allowed achievement of therapeutic goals at steady state. 3) Without computing individual pharmacokinetic parameters, nor using pharmacokinetic software, kinetic nomograms steered individual sirolimus blood levels within its therapeutic window with only two samples and in the first week after starting treatment. This contribution relates traditional Bayesian methods developed in 80’s but not yet fully integrated in clinical context because of their complexity. The contribution focuses on recent developments based on population approaches, rendering the dosage adjustment methodology a simple and quick bedside application.
Keywords: Bayesian estimation, dosage adjustment, inter-individual variability, pharmacokinetics, population approaches, therapeutic drug monitoring
Current Topics in Medicinal Chemistry
Title:Progress in Strategies for Dosage Regimen Individualization
Volume: 12 Issue: 15
Author(s): Hafedh Marouani, Christian Woloch, Stephan Benay, Nicolas Frances and Athanassios Iliadis
Affiliation:
Keywords: Bayesian estimation, dosage adjustment, inter-individual variability, pharmacokinetics, population approaches, therapeutic drug monitoring
Abstract: Several findings suggest that patient outcome would be improved with individualized doses. The aim of this paper is to describe major approaches, methods and underlying basic foundations implemented, in clinical practice, for dosage individualization. Also we propose a new method codified by kinetic nomograms as reliable alternative to traditional Bayesian methods. Clinical and simulation data were reported to evaluate performances of the proposed methods. Real examples of therapeutic drug monitoring were selected. Bayesian methods were used to individualize high-dose methotrexate rate infusion and amikacin dosage regimen, and kinetic nomograms to adjust sirolimus doses. 1) Using only few measurements, Bayesian method resulted in accurate estimates of individual pharmacokinetic parameters of highdose methotrexate infusion. Targeting a pre-defined end-of-infusion level, infusion rate was individualized according to the previously obtained pharmacokinetic parameters. 2) With the same reasoning, individual pharmacokinetic parameters of amikacin were obtained by Bayesian estimation using three individual samples. Subsequent dosage adjustment allowed achievement of therapeutic goals at steady state. 3) Without computing individual pharmacokinetic parameters, nor using pharmacokinetic software, kinetic nomograms steered individual sirolimus blood levels within its therapeutic window with only two samples and in the first week after starting treatment. This contribution relates traditional Bayesian methods developed in 80’s but not yet fully integrated in clinical context because of their complexity. The contribution focuses on recent developments based on population approaches, rendering the dosage adjustment methodology a simple and quick bedside application.
Export Options
About this article
Cite this article as:
Marouani Hafedh, Woloch Christian, Benay Stephan, Frances Nicolas and Iliadis Athanassios, Progress in Strategies for Dosage Regimen Individualization, Current Topics in Medicinal Chemistry 2012; 12 (15) . https://dx.doi.org/10.2174/156802612803531315
DOI https://dx.doi.org/10.2174/156802612803531315 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Adaptogens—History and Future Perspectives
Adaptogens are pharmacologically active compounds or plant extracts that are associated with the ability to enhance the body’s stability against stress. The intake of adaptogens is associated not only with a better ability to adapt to stress and maintain or normalise metabolic functions but also with better mental and physical ...read more
AlphaFold in Medicinal Chemistry: Opportunities and Challenges
AlphaFold, a groundbreaking AI tool for protein structure prediction, is revolutionizing drug discovery. Its near-atomic accuracy unlocks new avenues for designing targeted drugs and performing efficient virtual screening. However, AlphaFold's static predictions lack the dynamic nature of proteins, crucial for understanding drug action. This is especially true for multi-domain proteins, ...read more
Challenges, Consequences and Possible Treatments of Anticancer Drug Discovery ll
The use of several compounds has been the subject of increasing interest in phytochemistry, biochemistry, and other fields of research at the chemistry-biology-ecosystems interface. In spite of the continued search for new anticancer drugs, cancer remains a leading cause of death. Cancer mortalities are expected to increase to 12.9 million, ...read more
Chronic Kidney Disease
The scope of the special thematic issue includes but not limited to the mechanism of chronic kidney disease (CKD), the treatment of renal fibrosis and early diagnosis of CKD and so on. We also welcome manuscripts from other scientific research area with respect to internal medicine. Cell death has been ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Searching for Phytoinsulins as Cardiovascular Protector in Metabolic Syndrome
Current Pharmaceutical Design Effect of Simvastatin on Inflammatory Cytokines Balance in Air Pouch Granuloma Model
Inflammation & Allergy - Drug Targets (Discontinued) Natural Agents Modulating ACE-2: A Review of Compounds with Potential against SARS-CoV-2 Infections
Current Pharmaceutical Design Interest of Antioxidant Agents in Parasitic Diseases. The Case Study of Coumarins
Current Topics in Medicinal Chemistry Targeting Cyclooxygenase and Nitric Oxide Pathway Cross-Talk: A New Signal Transduction Pathway for Developing More Effective Anti- Inflammatory Drugs
Current Signal Transduction Therapy Treating the Cognitive Deficits of Schizophrenia with Alpha4Beta2 Neuronal Nicotinic Receptor Agonists
Current Pharmaceutical Design Synthesis and Biological Activities of Some Novel 2-Amino-(5 or 7-Substituted- 2-Oxoindolin-3-Ylidene) Benzoxazole-5-Carbohydrazide Derivatives
Letters in Drug Design & Discovery The Co-Metabolism within the Gut-Brain Metabolic Interaction: Potential Targets for Drug Treatment and Design
CNS & Neurological Disorders - Drug Targets Teenage-Pregnancies - A Biomedical and a Sociocultural Approach to a Current Problem
Current Women`s Health Reviews Potential of Nanotechnology-based Formulations in Combating Pulmonary Infectious Diseases: A Current Scenario
Current Pharmaceutical Design Structure, Function, and Pathogenesis of SHP2 in Developmental Disorders and Tumorigenesis
Current Cancer Drug Targets Current Therapeutic Approaches in Inflammatory Bowel Disease
Current Pharmaceutical Design Macrocyclic Compounds: Emerging Opportunities for Current Drug Discovery
Current Pharmaceutical Design WITHDRAWN: Current Trends in the Detection of Biological Proteins and Immunological Assays using Graphene Quantum Dots
Current Analytical Chemistry Neuroinflammation, Diabetes and COVID-19: Perspectives Coming from Ca<sup>2+</sup>/cAMP Signalling
Current Drug Research Reviews Recent Developments in Patented DC-Based Immunotherapy for Various Malignancies
Recent Patents on Regenerative Medicine The Effects of Physical and Psychological Stress on the Gastrointestinal Tract: Lessons from Animal Models
Current Molecular Medicine Chemoprotective Mechanism of the Natural Compounds, Epigallocatechin- 3-O-Gallate, Quercetin and Curcumin Against Cancer and Cardiovascular Diseases
Current Medicinal Chemistry Berberine Administration in Treatment of Colitis: A Review
Current Drug Targets Image Guidance in Stem Cell Therapeutics: Unfolding the Blindfold
Current Drug Targets